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Purpose: To investigate whether interleukin 10 (IL10) gene polymorphisms are associated with the development of
sarcoidosis in Japanese patients.
Methods: Two hundred and eighty-eight Japanese sarcoidosis patients and 310 Japanese healthy controls were recruited.
We genotyped 9 single-nucleotide polymorphisms in IL10 and assessed the allelic diversity between cases and controls.
Results: No significant differences in the frequency of IL10 alleles, genotypes, and haplotypes in the sarcoidosis cases
compared to the controls were detected.
Conclusions: Our results suggest that IL10 polymorphisms are not significantly related to the pathogenesis of sarcoidosis
in the Japanese population.
Sarcoidosis  is  a  systemic  inflammatory  disorder
characterized by non-caseating granuloma formation in many
organs, such as: lung, skin, eye, lymph nodes, central and
peripheral nervous system, and heart [1-3].
In Japan, the reported incidence rate of the disease is 1.01
per 100,000 inhabitants [4]. On a global scale, this incidence
rate is low. African Americans incidence rate of the disease is
35.5 per 100,000. That of Caucasian Americans is 10.9 per
100,000 [5]. Japanese patients have a higher likelihood of
ocular involvement compared with other ethnic groups [4,6].
According to a recent epidemiological study of sarcoidosis in
Japan, patients with ocular involvement was 54.8% of cases
and impaired vision was the most frequent symptom (28.8%)
[4]. In European patients, erythema nodosum of skin lesions
is commonly seen. It is rare in Japanese patients [7]. This way,
the frequency and course of sarcoidosis varies widely among
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racial  groups.  It  supports  the  assumption  that  some
predisposing genetic factors play roles in the development of
the disease. There is also evidence supporting a possibility of
association with genetic factors. Some familial sarcoidosis
cases [8], and associations between the disease and human
leukocyte antigen (HLA) systems were reported [9,10]. The
exact cause of the disease remains undetermined, but it is
currently thought that genetic factors may be the basis of
disease susceptibility.
It is also thought that environmental factors associate
with  the  disease  progression.  By  using  polymerase-chain-
reaction (PCR) techniques, Mycobacterium tuberculosis and
Propionibacterium acnes DNA have been detected in sarcoid
lesions  [11-14].  Recent  studies  have  shown  that  serum
samples from sarcoidosis patients contain antibodies against
mycobacterium  antigens  [15].These  studies  suggest  that
immune  responses  to  bacterial  infections  can  affect  the
development of sarcoidosis.
The  inflammatory  response  in  sarcoidosis  is
characterized  by  the  increased  production  of  several
inflammatory cytokines produced by type 1 helper T (Th1)
cells  and  macrophages,  such  as  interleukin-2  (IL-2),
interferon-gamma (IFN-γ), and tumor necrosis factor alpha
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512(TNF-α) [16-18]. These cytokines seem to play a roll leading
to the formation of granuloma [3]. In some of sarcoidosis
patients,  the  granulomatous  response  resolves,  and  the
remaining  patients  have  chronic  disease  include  fibrosis.
Interleukin-10 (IL-10) produced by type 2 helper T (Th2) cells
is  associated  with  the  resolution  [3].  IL-10  is  a  potent
suppressor  of  these  inflammatory  cytokines  [19].  Several
studies reported that changes in cytokine production might
have been caused by a genetic polymorphisms and some of
them  might  be  involved  in  disease  susceptibility  and
progression.  Recent  studies  have  reported  that  IL10
polymorphisms were associated with several inflammatory
diseases  [20-22].  In  the  present  study,  we  evaluated  the
association of multiple SNPs in IL10 in Japanese sarcoidosis
patients.
METHODS
Subjects: Two hundred and eighty-eight unrelated patients
with a diagnosis of sarcoidosis and 310 healthy controls were
recruited  from  Yokohama  City  University,  Hokkaido
University, Fujita Health University, Tokyo University, Keio
University, Kumamoto City hospital and Yuasa eye clinic. All
patients and control participants were of Japanese ethnicity.
Sarcoidosis  patients  were  diagnosed  according  to  the
diagnostic  criteria  developed  by  the  Japanese  Society  of
Sarcoidosis  and  Other  Granulomatous  Disorders  (JSSOG)
previously  described  [23].  Uveitis  with  sarcoidosis  was
assessed based on the “Guidelines for Diagnosis of Ocular
Lesions in Sarcoidosis” prepared by the JSSOG. The ocular
features of sarcoidosis were defined as granulomatous uveitis
plus two or more of the following: infiltration of the anterior
chamber  (mutton-fat  keratic  precipitates/iris  nodules),
trabecular meshwork nodules and/or tent-shaped peripheral
anterior synechia, masses of vitreous opacities (snowball-like
or  string  of  pearls-like  appearance),  periphlebitis  with
perivascular nodules; multiple candle-wax type chorioretinal
exudates and nodules, and/or laser photocoagulation spot-like
chorioretinal  atrophy.  All  subjects  had  a  similar  social
background and resided in the same urban area. The research
methods  were  in  compliance  with  the  guidelines  of  the
Declaration of Helsinki. Details of the study were explained
to all patients and controls, and valid consent for genetic
screening was obtained.
IL10  genotyping:  Peripheral  blood  lymphocytes  were
collected, and genomic DNA was extracted from peripheral
blood cells using the QIAamp DNA Blood Maxi Kit (Qiagen,
Tokyo,  Japan).  We  selected  IL10  SNPs  which  previously
showed  a  significant  association  with  Japanese  Behcet’s
disease [22]: rs1878672, rs1554286, rs1518111, rs3021094,
rs3790622,  rs3024490,  rs1800872,  rs1800871,  and
rs1800896 (Figure 1, Table 1). Genotyping of all SNPs was
performed  using  the  TaqMan  5′exonuclease  assay  using
primers supplied by Applied Biosystems (Foster City, CA).
Figure 1. Linkage disequilibrium plot of
nine SNPs in IL10 SNPs in 598 study
participants. The D’ value and r2 value
(in parentheses) corresponding to each
SNP pair are expressed as a percentage
and shown within the respective square.
Higher D’ is indicated by a brighter red.
The 9 SNPs constitute a haplotype block
spanning 3.2 kb of IL10.
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515Probe fluorescence signals were detected by TaqMan Assay
for real-time PCR (7500 Real Time PCR System; Applied
Biosystems) following the manufacturer’s instructions.
Statistical analysis: Hardy–Weinberg equilibrium was tested
for each SNP among the controls. Differences in allele and
genotype  frequencies  between  cases  and  controls  were
assessed by the χ2 test. The Haploview 4.1 program was used
to compute pair-wise linkage disequilibrium (LD) statistics
[24]. Standardized disequilibrium D’ value and r2 value were
plotted, and LD blocks were defined according to the criteria
[25].  Haplotype  frequencies  were  estimated  with  an
accelerated expectation-maximization algorithm, similar to
the  partition-ligation-expectation-maximization  method
described previously [26]. P values <0.05 were considered
statistically significant.
RESULTS
We  genotyped  nine  common  SNPs  in  IL10:  rs1878672,
rs1554286,  rs1518111,  rs3021094,  rs3790622,  rs3024490,
rs1800872,  rs1800871,  and  rs1800896.  All  SNPs  were  in
Hardy–Weinberg  equilibrium  in  the  controls  (data  not
shown). All 9 SNPs were located in 1 haplotype block, and
the magnitude of LD between each SNP was extremely high,
with pair-wise D’≥0.83 (Figure 1). The allele and genotype
frequencies of the 9 SNPs in both the cases and controls are
listed in Table 1 and Table2, respectively. No statistically
significant association was observed for any of the SNPs
between the cases and controls. Furthermore, there were no
significant differences in the haplotype frequencies of all 9
SNPs between the cases and controls (Table 3). We analyzed
clinical features according to 9 SNPs. In a stratified analysis
according to lesion location, which included the eye, lungs,
skin heart, and nerves, none of these clinical features were
found to be significantly associated with 9 SNPs (data not
shown).
DISCUSSION
The  aim  of  the  current  study  was  to  investigate  whether
IL10  polymorphisms  affect  the  development  of  Japanese
patients  with  sarcoidosis.  Our  results  showed  that  all  the
IL10 polymorphisms were not significantly associated with
any  clinical  subtype  of  sarcoidosis  including  ocular
involvement in Japanese patients. Here we report a lack of
association between IL10 variants and Japanese sarcoidosis
patients,  suggesting  that  the  possibility  of  attributing  the
pathogenesis of sarcoidosis to IL10 genetic variations is low.
IL-10 poroduced by Th2 cells suppresses inflammatory
cytokines produced by Th1 cells. Although the mechanism of
IL-10 in sarcoidosis is unclear, it is thought to be associated
with granuloma resolution [2,3]. Some studies have reported
that  serum  levels  of  IL-10  were  increased  in  several
inflammatory  diseases,  such  as;  Crohn’s  disease,  diffuse
cutaneous  systemic  sclerosis  and  active  Behçet's  disease
[27-29].  In  addition,  increased  serum  levels  of  IL-10  in
sarcoidosis patients have been reported [30,31].
Recent  studies  have  also  reported  that  IL10  gene
polymorphisms were associated with several inflammatory
diseases. Wang et al. [20] reported IL-10 concentration was
significantly higher in Crohn’s disease patients than in the
controls  and  IL10  polymorphisms  were  associated  with
increased  patient  serum  IL-10  levels.  Hudson  et  al.  [21]
reported that IL10 genotypes were associated with systemic
sclerosis-related autoantibodies and contribute to the etiology
of systemic sclerosis. Recently, Mizuki et al. [22] performed
a genome-wide association study for Behect’s disease and
identified IL10 as a disease susceptibility gene. Muraközy et
al. [32] investigated an association of IL10 polymorphisms
with sarcoidosis, however they could not find any significant
differences. As with the previous report, we could not find any
association  between  IL10  gene  polymorphisms  and
sarcoidosis. On the other hand, Vasakova et al. [33] have
recently shown that there are significant differences in the
frequencies of IL10 polymorphisms between sarcoidosis and
healthy controls in the Czech Caucasian population, whereas
they suggested that their findings cannot be generalized since
the sample size in the study was small.
In summary, the IL10 polymorphisms do not appear to be
significantly  relevant  to  Japanese  sarcoidosis  patients.
However, further genetic studies in other ethnic populations
TABLE 3. HAPLOTYPE FREQUENCIES OF SNPS OF THE IL10 GENE AMONG CASES AND CONTROLS.
 
Haplotype Frequency, %
   
Haplotype Cases n=288 Controls n=310 p OR (95%CI)
(rs1878672, rs1554286, rs1518111, rs3021094, rs3790622, rs3024490, rs1800872, rs1800871, and rs1800896) 
CTACCTATA 32.6 32.4 0.934 1.01 (0.79–1.29)
CTAACTATA 28.0 26.1 0.461 1.10 (0.85–1.42)
CCGACGCCA 26.0 27.3 0.605 0.93 (0.72–1.21)
GCGACGCCG 5.4 6.5 0.410 0.82 (0.50–1.32)
CTACTTATA 6.3 4.9 0.304 1.30 (0.79–2.14)
CTAACGATA 1.7 2.5 0.396 0.71 (0.31–1.58)
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516are  required  to  elucidate  the  association  between  IL10
polymorphisms and sarcoidosis.
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